Quarterly report · Q2

Period2023-06-01 → 2023-11-30
Filed2024-01-12
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 51
MetricValuePeriodScopeSource row
Revenue¥2.9bn2023-06-01 → 2023-11-30StandaloneNet sales
Revenue¥6.3bn2022-06-01 → 2023-05-31StandaloneNet sales (5-year summary)
Revenue¥3.1bn2022-06-01 → 2022-11-30StandaloneNet sales
Operating income¥115m2023-06-01 → 2023-11-30StandaloneOperating income
Operating income¥225m2022-06-01 → 2022-11-30StandaloneOperating income
Ordinary income¥110m2023-06-01 → 2023-11-30StandaloneOrdinary income
Ordinary income¥351m2022-06-01 → 2023-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥208m2022-06-01 → 2022-11-30StandaloneOrdinary income
Profit before tax¥145m2023-06-01 → 2023-11-30StandaloneIncome before income taxes
Profit before tax¥208m2022-06-01 → 2022-11-30StandaloneIncome before income taxes
Net income¥93m2023-06-01 → 2023-11-30StandaloneProfit loss
Net income¥256m2022-06-01 → 2023-05-31StandaloneNet income loss (5-year summary)
Net income¥149m2022-06-01 → 2022-11-30StandaloneProfit loss
Total assets¥5.1bnat 2023-11-30StandaloneAssets
Total assets¥4.9bnat 2023-05-31StandaloneAssets
Total assets¥5.0bnat 2022-11-30StandaloneTotal assets (5-year summary)
Total liabilities¥3.1bnat 2023-11-30StandaloneLiabilities
Total liabilities¥3.0bnat 2023-05-31StandaloneLiabilities
Net assets / equity¥2.0bnat 2023-11-30StandaloneNet assets
Net assets / equity¥1.9bnat 2023-05-31StandaloneNet assets
Net assets / equity¥1.8bnat 2022-11-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2023-11-30StandaloneCash and deposits
Cash and deposits¥853mat 2023-05-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2023-11-30StandaloneCash and cash equivalents
Cash & equivalents¥853mat 2023-05-31StandaloneCash and cash equivalents
Cash & equivalents¥765mat 2022-11-30StandaloneCash and cash equivalents
Cash & equivalents¥865mat 2022-05-31dStandaloneCash and cash equivalents
Operating cash flow¥143m2023-06-01 → 2023-11-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥317m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥58m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥115m2023-06-01 → 2023-11-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥162m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥69m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥185m2023-06-01 → 2023-11-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥172m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥28m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥23.632023-06-01 → 2023-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥17.852023-09-01 → 2023-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-06-01 → 2023-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥39.922022-06-01 → 2022-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥16.82022-09-01 → 2022-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥23.162023-06-01 → 2023-11-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥64.122022-06-01 → 2023-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥38.622022-06-01 → 2022-11-30StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥192022-06-01 → 2023-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio38.9%at 2023-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio38.7%at 2023-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.8%at 2022-11-30StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2023-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2023-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-11-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue2023-06-01 → 2023-11-30¥1.0bn
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue external2023-06-01 → 2023-11-30¥1.0bn
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentsegment profit2023-06-01 → 2023-11-30−¥55m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue2023-06-01 → 2023-11-30¥379m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue external2023-06-01 → 2023-11-30¥379m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentsegment profit2023-06-01 → 2023-11-30−¥28m
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue2023-06-01 → 2023-11-30¥1.5bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2023-06-01 → 2023-11-30¥1.5bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2023-06-01 → 2023-11-30¥198m
—segment totalrevenue2023-06-01 → 2023-11-30¥2.9bn
—segment totalrevenue external2023-06-01 → 2023-11-30¥2.9bn
—segment totalsegment profit2023-06-01 → 2023-11-30¥115m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2023-11-30¥2.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2023-11-30¥2.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2023-11-30¥115m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥965m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥965m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥20m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥377m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥377m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥39m
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥1.8bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥1.8bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2022-11-30¥284m
—segment totalrevenue2022-06-01 → 2022-11-30¥3.1bn
—segment totalrevenue external2022-06-01 → 2022-11-30¥3.1bn
—segment totalsegment profit2022-06-01 → 2022-11-30¥225m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-11-30¥3.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-11-30¥3.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-11-30¥225m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 517
ItemContextValueUnit
Independent auditors report non consolidated (text)FilingDateInstantText · Plus
Audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)有限責任監査法人ト ー マ ツ
Cpa1 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese) 寺  田  篤  芳
Cpa2 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese) 宮  嵜    健
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration_NonConsolidatedMember3121245000JPY
Net sales (5-year summary)CurrentYTDDuration_NonConsolidatedMember2912325000JPY
Net sales (5-year summary)Prior1YearDuration_NonConsolidatedMember6291379000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration_NonConsolidatedMember207911000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration_NonConsolidatedMember110087000JPY
Ordinary income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember350890000JPY
Net income loss (5-year summary)Prior1YTDDuration_NonConsolidatedMember149290000JPY
Net income loss (5-year summary)CurrentYTDDuration_NonConsolidatedMember93234000JPY
Net income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember256302000JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YTDDuration_NonConsolidatedMember-JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)CurrentYTDDuration_NonConsolidatedMember-JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YearDuration_NonConsolidatedMember-JPY
Capital stock (5-year summary)Prior1QuarterInstant_NonConsolidatedMember143172000JPY
Capital stock (5-year summary)CurrentQuarterInstant_NonConsolidatedMember143172000JPY
Capital stock (5-year summary)Prior1YearInstant_NonConsolidatedMember143172000JPY
Total number of issued shares (5-year summary)Prior1QuarterInstant_NonConsolidatedMember4095500
Total number of issued shares (5-year summary)CurrentQuarterInstant_NonConsolidatedMember4095500
Total number of issued shares (5-year summary)Prior1YearInstant_NonConsolidatedMember4095500
Net assets (5-year summary)Prior1QuarterInstant_NonConsolidatedMember1787706000JPY
Net assets (5-year summary)CurrentQuarterInstant_NonConsolidatedMember1977580000JPY
Net assets (5-year summary)Prior1YearInstant_NonConsolidatedMember1915229000JPY
Total assets (5-year summary)Prior1QuarterInstant_NonConsolidatedMember4994344000JPY
Total assets (5-year summary)CurrentQuarterInstant_NonConsolidatedMember5081891000JPY
Total assets (5-year summary)Prior1YearInstant_NonConsolidatedMember4948311000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember39.92
Basic earnings loss per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember23.63
Basic earnings loss per share (5-year summary)Prior1YearDuration_NonConsolidatedMember67.94
Diluted earnings per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember38.62
Diluted earnings per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember23.16
Diluted earnings per share (5-year summary)Prior1YearDuration_NonConsolidatedMember64.12
Dividend paid per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember-
Dividend paid per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember-
Dividend paid per share (5-year summary)Prior1YearDuration_NonConsolidatedMember19.00
Equity to asset ratio (5-year summary)Prior1QuarterInstant_NonConsolidatedMember0.358
Equity to asset ratio (5-year summary)CurrentQuarterInstant_NonConsolidatedMember0.389
Equity to asset ratio (5-year summary)Prior1YearInstant_NonConsolidatedMember0.387
Net cash provided by used in operating activities (5-year summary)Prior1YTDDuration_NonConsolidatedMember-58498000JPY
Net cash provided by used in operating activities (5-year summary)CurrentYTDDuration_NonConsolidatedMember143152000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration_NonConsolidatedMember317189000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YTDDuration_NonConsolidatedMember-69475000JPY
Net cash provided by used in investing activities (5-year summary)CurrentYTDDuration_NonConsolidatedMember-115474000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration_NonConsolidatedMember-162408000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YTDDuration_NonConsolidatedMember28064000JPY
Net cash provided by used in financing activities (5-year summary)CurrentYTDDuration_NonConsolidatedMember185472000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration_NonConsolidatedMember-172390000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-05-31pass
balance sheet identitynon_consolidated 2023-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-05-31pass
statement vs summary · net assetsnon_consolidated 2023-11-30pass
statement vs summary · operating cash flownon_consolidated 2022-06-01/2022-11-30pass
statement vs summary · operating cash flownon_consolidated 2023-06-01/2023-11-30pass
statement vs summary · revenuenon_consolidated 2022-06-01/2022-11-30pass
statement vs summary · revenuenon_consolidated 2023-06-01/2023-11-30pass
statement vs summary · total assetsnon_consolidated 2023-05-31pass
statement vs summary · total assetsnon_consolidated 2023-11-30pass